Concepedia

S. Pezzulli

SP

Statistics

Publications

12

Citations

853

H-Index

11

Active since

2002

Affiliations

Memorial Sloan Kettering Cancer Center(Current)

Cornell University

City of Hope

The University of Texas MD Anderson Cancer Center

S. Pezzulli is an author at Memorial Sloan Kettering Cancer Center specializing in pharmacology, medicine, and cancer pharmacology.

Publications per year

2002–2011

12

Publications

12

A phase I trial of the novel proteasome inhibitor PS341 in advanced solid tumor malignancies.

Carol Aghajanian, Steven L. Soignet, Don S. Dizon et al. · PubMed · 2002 · 456 citations

, , +14

Safety and Immunogenicity Study of NY-ESO-1b Peptide and Montanide ISA-51 Vaccination of Patients with Epithelial Ovarian Cancer in High-Risk First Remission

Catherine Diefenbach, Sacha Gnjatic, Paul Sabbatini et al. · Clinical Cancer Research · 2008 · 105 citations · Full text

, , +17

Phase 1 Study of Aflibercept Administered Subcutaneously to Patients with Advanced Solid Tumors

William P. Tew, Michael S. Gordon, John R. Murren et al. · Clinical Cancer Research · 2009 · 89 citations · Full text

, , +17

Phase II Study of Intraperitoneal Paclitaxel Plus Cisplatin and Intravenous Paclitaxel Plus Bevacizumab As Adjuvant Treatment of Optimal Stage II/III Epithelial Ovarian Cancer

Jason Konner, Diana M. Grabon, Scott R. Gerst et al. · Journal of Clinical Oncology · 2011 · 51 citations · Full text

, , +16

Phase II study of tirapazamine plus cisplatin in patients with advanced or recurrent cervical cancer

Fernando Cotait Maluf, Aliza Leiser, Carol Aghajanian et al. · International Journal of Gynecological Cancer · 2006 · 35 citations

, , +17

1–5 of 12